Search

Your search keyword '"Witzel, I."' showing total 205 results

Search Constraints

Start Over You searched for: Author "Witzel, I." Remove constraint Author: "Witzel, I." Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
205 results on '"Witzel, I."'

Search Results

2. Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriers

4. Assessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task Force

5. 208P Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases: A subanalysis of the German brain metastases in breast cancer registry (BMBC)

7. Long-term survival of HER2-positive breast cancer patients with brain metastases: subanalysis of the BMBC Registry

9. 269P Long-term survival of HER2-positive breast cancer patients with brain metastases: Subanalysis of the BMBC registry

10. 151P Tumor biology and immunology in patients (pts) with breast cancer occurring during pregnancy (BCP) compared to non-pregnant breast cancer pts

11. Long-term survival of HER2-positive breast cancer patients with brain metastases: Subanalysis of the BMBC registry

12. Long-term survival of breast cancer patients with brain metastases: Subanalysis of the BMBC registry

13. 170P Long-term survival of breast cancer patients with brain metastases: Subanalysis of the BMBC registry

15. Characteristics of patients with brain metastases from HER2-positive breast cancer

16. 95MO Characteristics of patients with brain metastases from HER2-positive breast cancer

17. Clinical-pathological Characterization of 1078 Advice Seekers with pathogenic CHEK2 Mutation from the German Consortium of Familial Breast and Ovarian Cancer (DK-FBREK)

19. 44O Pembrolizumab (pembro) vs chemotherapy (chemo) for previously treated metastatic triple-negative breast cancer (mTNBC): KEYNOTE-119 Asia-Pacific subpopulation

20. Charakteristika und Überlebensanalyse der Patienten mit asymptomatischen Hirnmetastasen eines Mammakarzinoms

22. Klinisch-pathologische Charakterisierung von 1078 Ratsuchenden mit pathogener CHEK2 Mutation aus dem Deutschen Konsortium Familiärer Brust- und Eierstockkrebs (DK-FBREK)

24. 149P Predicting prognosis of breast cancer patients with brain metastases in the BMBC registry: Comparison of three different prognostic scores

26. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification.

27. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification

28. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification

29. KEYNOTE-119: Phase III study of pembrolizumab (pembro) versus single-agent chemotherapy (chemo) for metastatic triple negative breast cancer (mTNBC)

30. PRECYCLE: Impact of CANKADO-based eHealth-support on quality of life in metastatic breast cancer patients treated with palbociclib and endocrine therapy

31. New structures of the German Consortium for Hereditary Breast and Ovarian Cancer

32. Role of urokinase plasminogen activator and plasminogen activator inhibitor mRNA expression as prognostic factors in molecular subtypes of breast cancer

35. The clinical relevance of circulating tumor cells in correlation to other serum biomarkers (VEGF, HER2, EGFR, TIMP1, CAIX, RASp21) in patients with metastatic breast cancer

36. Validierung des Breast-GPA Scores bei Patientinnen mit Hirnmetastasen eines Mammakarzinoms im BMBC-Register (GBG-79)

38. Expression Levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in Primary Breast Carcinoma and Distant Breast Cancer Metastases

40. Evaluation von Option Grids zur Unterstützung der Partizipativen Entscheidungsfindung in der Brustkrebsbehandlung – ein Studienprotokoll

46. Abstract P6-17-08: Brain metastases in breast cancer network Germany (BMBC, GBG 79): First analysis of 548 patients from the multicenter registry

47. Abstract P5-07-03: Prosigna® results impact on adjuvant decision making in early breast cancer (EBC): Final analysis of the prospective WSG study

49. Identifying common genetic risk factors of diabetic neuropathies

50. Partial PTEN deletion is linked to poor prognosis in breast cancer

Catalog

Books, media, physical & digital resources